699 related articles for article (PubMed ID: 14499793)
1. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
Hookman P; Barkin JS
Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
[TBL] [Abstract][Full Text] [Related]
2. Metformin reverses fatty liver disease in obese, leptin-deficient mice.
Lin HZ; Yang SQ; Chuckaree C; Kuhajda F; Ronnet G; Diehl AM
Nat Med; 2000 Sep; 6(9):998-1003. PubMed ID: 10973319
[TBL] [Abstract][Full Text] [Related]
3. [Study on therapeutic effects of metformin on rat fatty livers induced by high fat feeding].
Gao ZQ; Lu FE; Dong H; Xu LJ; Wang KF; Zhou X
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):101-4. PubMed ID: 15727694
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels.
Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
J Pathol; 2006 Jan; 208(1):74-81. PubMed ID: 16261527
[TBL] [Abstract][Full Text] [Related]
5. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats.
Raju J; Bird RP
Int J Obes (Lond); 2006 Aug; 30(8):1298-307. PubMed ID: 16477270
[TBL] [Abstract][Full Text] [Related]
6. Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice.
García-Ruiz I; Rodríguez-Juan C; Díaz-Sanjuan T; del Hoyo P; Colina F; Muñoz-Yagüe T; Solís-Herruzo JA
Hepatology; 2006 Sep; 44(3):581-91. PubMed ID: 16941682
[TBL] [Abstract][Full Text] [Related]
7. [Effects of metformin on fatty liver in insulin-resistant rats].
Chen SQ; Liu Q; Sun H; Tang L; Deng JC
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):915-8. PubMed ID: 16381638
[TBL] [Abstract][Full Text] [Related]
8. Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of Fatty liver inflammation in obese mice.
Bigorgne AE; Bouchet-Delbos L; Naveau S; Dagher I; Prévot S; Durand-Gasselin I; Couderc J; Valet P; Emilie D; Perlemuter G
Gastroenterology; 2008 May; 134(5):1459-69. PubMed ID: 18471520
[TBL] [Abstract][Full Text] [Related]
9. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
10. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
[TBL] [Abstract][Full Text] [Related]
14. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?
Yang S; Lin HZ; Hwang J; Chacko VP; Diehl AM
Cancer Res; 2001 Jul; 61(13):5016-23. PubMed ID: 11431335
[TBL] [Abstract][Full Text] [Related]
15. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
Zheng LY; Pan JQ; Lv JH
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
[TBL] [Abstract][Full Text] [Related]
16. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
17. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.
Li Z; Soloski MJ; Diehl AM
Hepatology; 2005 Oct; 42(4):880-5. PubMed ID: 16175608
[TBL] [Abstract][Full Text] [Related]
18. Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice.
Park HJ; DiNatale DA; Chung MY; Park YK; Lee JY; Koo SI; O'Connor M; Manautou JE; Bruno RS
J Nutr Biochem; 2011 Apr; 22(4):393-400. PubMed ID: 20655714
[TBL] [Abstract][Full Text] [Related]
19. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
